Literature DB >> 19804590

Human eyelash characterization.

S Thibaut1, E De Becker, L Caisey, D Baras, S Karatas, O Jammayrac, P J Pisella, B A Bernard.   

Abstract

BACKGROUND: Few biological data on human eyelash follicles have been reported in the literature.
OBJECTIVES: To characterize eyelash follicle growth, cycle and morphology, and further investigate the biological mechanisms that determine eyelash length, curl and pigmentation, compared with scalp hair follicle.
METHODS: Twenty-nine caucasian female volunteers aged between 26 and 60 years were enrolled in the study to provide eyelashes. Four of these volunteers were followed weekly for 9 months to characterize their eyelash cycle. Eyelash length and time of renewal were measured using a high-resolution camera and image analysis. Immunohistological study of the bulbs were performed on eyelid biopsies from 17 patients requiring block excision for ectropion repair.
RESULTS: The calculated durations of anagen phase and complete cycle of the eyelashes were 34 + or - 9 and 90 + or - 5 days, respectively. Eyelash follicle growth rate was quite variable, with an average rate of 0.12 + or - 0.05 mm daily. Eyelash follicle morphology was very close to that of the scalp hair follicle, but some remarkable differences were noticed. For example, the K19-positive epithelial stem cell population was spread all along the follicle and not split into two reservoirs as seen in scalp hair follicles. Some asymmetry was detected in HSPG and CSPG, as well as K38 (formerly Ha8) and K82 (formerly Hb2) distribution, similar to that observed in curly hair. Finally, dopachrome tautomerase was found expressed in eyelash follicle melanocytes, while it was strikingly absent in scalp hair follicle melanocytes.
CONCLUSIONS: The eyelash is structurally very close to curly hair but some biological processes related to follicle cycle and pigmentation differ markedly.

Entities:  

Mesh:

Year:  2009        PMID: 19804590     DOI: 10.1111/j.1365-2133.2009.09487.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  8 in total

1.  How eyelashes can protect the eye through inhibiting ocular water evaporation: a chemical engineering perspective.

Authors:  Siyu Zou; Jinping Zha; Jie Xiao; Xiao Dong Chen
Journal:  J R Soc Interface       Date:  2019-10-09       Impact factor: 4.118

2.  FGF5 is a crucial regulator of hair length in humans.

Authors:  Claire A Higgins; Lynn Petukhova; Sivan Harel; Yuan Y Ho; Esther Drill; Lawrence Shapiro; Muhammad Wajid; Angela M Christiano
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-02       Impact factor: 11.205

Review 3.  Eyebrow and Eyelash Alopecia: A Clinical Review.

Authors:  Betty Nguyen; Jamie Katy Hu; Antonella Tosti
Journal:  Am J Clin Dermatol       Date:  2022-10-02       Impact factor: 6.233

4.  The effect of 0.02% mitomycin C injection into the hair follicle with radiofrequency ablation in trichiasis patients.

Authors:  Gyu-Nam Kim; Woong-Sun Yoo; Seong-Jae Kim; Yong-Seop Han; In-Young Chung; Jong-Moon Park; Ji-Myong Yoo; Seong-Wook Seo
Journal:  Korean J Ophthalmol       Date:  2014-01-21

5.  Age estimation using level of eyebrow and eyelash whitening.

Authors:  Feride Aylin Kantarcı; Muhammed Nabi Kantarcı; Sefer Bilgi
Journal:  Med Sci Monit       Date:  2014-01-22

6.  Potential Effect of Epilation on the Outcome of Surgery for Trachomatous Trichiasis.

Authors:  Sandra Liliana Talero; Beatriz Muñoz; Sheila K West
Journal:  Transl Vis Sci Technol       Date:  2019-08-21       Impact factor: 3.283

7.  The prostamide-related glaucoma therapy, bimatoprost, offers a novel approach for treating scalp alopecias.

Authors:  Karzan G Khidhir; David F Woodward; Nilofer P Farjo; Bessam K Farjo; Elaine S Tang; Jenny W Wang; Steven M Picksley; Valerie A Randall
Journal:  FASEB J       Date:  2012-10-26       Impact factor: 5.191

Review 8.  The eyelash follicle features and anomalies: A review.

Authors:  Sarah Aumond; Etty Bitton
Journal:  J Optom       Date:  2018-07-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.